LIFEXP Nattokinase + Lumbrokinase is a dual-enzyme formulation designed to support cardiovascular health, enhance microcirculatory flow, and assist in the safe breakdown of excess fibrin. These proteolytic enzymes exhibit fibrinolytic, anti-inflammatory, and biofilm-disrupting properties, making them powerful agents in systemic health, vascular recovery, and adjunctive care for chronic inflammatory and circulatory conditions.
• Nattokinase is a single enzyme derived from natto, a traditional Japanese fermented soybean product (Bacillus subtilis natto).
• Lumbrokinase is a complex of fibrinolytic enzymes extracted from the earthworm Lumbricus rubellus, known for its multi-targeted enzymatic activity and superior stability.
OVERVIEW
LIFEXP Nattokinase + Lumbrokinase is a dual-enzyme formulation designed to support cardiovascular health, enhance microcirculatory flow, and assist in the safe breakdown of excess fibrin. These proteolytic enzymes exhibit fibrinolytic, anti-inflammatory, and biofilm-disrupting properties, making them powerful agents in systemic health, vascular recovery, and adjunctive care for chronic inflammatory and circulatory conditions.
• Nattokinase is a single enzyme derived from natto, a traditional Japanese fermented soybean product (Bacillus subtilis natto).
• Lumbrokinase is a complex of fibrinolytic enzymes extracted from the earthworm Lumbricus rubellus, known for its multi-targeted enzymatic activity and superior stability.
Key Features and Clinical Actions
Fibrinolytic Activity
• Both enzymes actively break down fibrin, a protein that contributes to blood clot formation and vascular obstruction.
• Lumbrokinase supports plasminogen activation, enhancing the body’s ability to naturally dissolve clots.
Microcirculatory & Anti-Inflammatory Effects
• Improves blood viscosity, oxygen delivery, and capillary perfusion.
• Reduces cell adhesion and inflammation, supporting vascular recovery post-surgery or post-infection.
Broader Therapeutic Potential
• Lumbrokinase has been studied for potential anti-tumor activity, especially in reducing metastasis and tumor cell adhesion.
• May support wound healing and tissue regeneration by modulating inflammation and promoting healthy circulation.
Ophthalmologic Applications
The combination offers emerging promise in managing vascular-related eye conditions through fibrinolytic and anti-inflammatory pathways:
1. Retinal Vein Occlusion (RVO) – May assist in reducing fibrin load and restoring retinal perfusion.
2. Diabetic Retinopathy – May improve microvascular circulation and reduce endothelial stress.
3. Glaucoma – May provide adjunctive optic nerve support through enhanced blood flow and mitochondrial defence.
Biofilm Disruption Activity
• Nattokinase interferes with the extracellular matrix of bacterial biofilms, particularly against Streptococcus mutansand Enterococcus faecalis.
• Lumbrokinase contributes to biofilm dismantling, which may enhance treatment of chronic infections associated with biofilm resistance.
FEATURES
• Promotes healthy blood viscosity and circulatory flow
• Supports fibrinolytic activity to help break down excess fibrin
• May aid in recovery from inflammation-related vascular damage
• Enhances nutrient and oxygen delivery to tissues and organs
• Useful as a systemic enzyme in post-viral, sedentary, or aging populations
Ideal For:
• Adults with cardiovascular risk factors or sedentary lifestyles
• Post-inflammatory or post-viral vascular support
• Individuals recovering from long flights or immobilization
• Those seeking proactive vascular longevity support
DIRECTION OF USE
General Support Dose:
Take 1 capsule once daily on an empty stomach, at least 1 hour before or 2 hours after meals. Best taken in the morning or midday.
Therapeutic Dose (Practitioner-Guided):
Take 1 capsule twice daily, morning and mid-afternoon, on an empty stomach.
Recommended for individuals with increased fibrin burden, sluggish circulation, or recovering from vascular stress (e.g., travel, inflammation, immobilization).
Note:
Do not use with anticoagulant or antiplatelet medications unless under supervision. Discontinue 5–7 days before surgery.